Fierce Pharma
OCTOBER 1, 2024
Johnson & Johnson is laying off 231 employees in New Jersey and Bayer is cutting 57 positions in the state, according to separate Worker Adjustment and Retraining Notification (WARN)
MedCity News
OCTOBER 1, 2024
Mental health company Lyra Health is now offering services for people struggling with cannabis, stimulants, opioids and nicotine. The post Lyra Health Expands Substance Use Disorder Support appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 1, 2024
Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million shares in Haleon for 380 pence (roughly $5.09) apiece. The sale amounts to a total value of 2.43 billion pounds sterling (about $3.26 billion) and follows a similar move in March.
MedCity News
OCTOBER 1, 2024
Kailera Therapeutics licensed its portfolio of metabolic disorder drugs from Hengrui. The most advanced program has results from a Phase 2 test in China suggesting it could be competitive with other medications that target the GLP-1 and GIP receptors to trigger weight loss. The post Metabolic Meds Biotech Kailera Launches With $400M for Next-Generation Weight-Loss Drugs appeared first on MedCity News.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Fierce Pharma
OCTOBER 1, 2024
No large pharma company has traversed this decade's ups and downs quite like Pfizer. | No large pharma company has traversed this decade's ups and downs quite like Pfizer. As the company rolls ahead with a large restructuring campaign, some staffers in Ireland will soon feel the effects.
MedCity News
OCTOBER 1, 2024
CMS recently finalized the Patient Safety Structural Measure, which sets forth a broad roadmap for the implementation of a culture of safety, learning, transparency and accountability within hospitals and health systems nationwide — enabling and encouraging significant progress towards safer care and improved support for healthcare workers. The post Patient Safety Structural Measure Marks Progress Towards Safer and Compassionate Care appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
OCTOBER 1, 2024
Autonomous coding startup Nym raised $47 million. The New York City-based company has 21 provider customers, including Geisinger and Ochsner Health. The post Nym Rakes In $47M for Autonomous Coding Engine appeared first on MedCity News.
Pharmaceutical Technology
OCTOBER 1, 2024
Otulfi is the fourth Stelara biosimilar approved in the US but will not launch until early 2025.
MedCity News
OCTOBER 1, 2024
Innovative approaches to home care will only be successful if organizations can ensure the safety of the professionals who enter patient homes. To do that, they’ll need to embrace new technologies that support in-home caregivers in real-time, and implement new protocols that ensure they are provided with the security and comfort they deserve. The post Staff Safety is Key to Sustaining Home Health Growth appeared first on MedCity News.
European Pharmaceutical Review
OCTOBER 1, 2024
A paper has demonstrated a novel application of optimising processes to implement inverse design in pharmaceutical manufacturing. Machine learning techniques were assessed for use as a surrogate model to optimise a three-unit wet-granulation based flowsheet model for the manufacture of solid dosage forms. Dan et al. highlighted that recent research has begun to investigate the potential applications of deep learning in process development, however currently, use of this technique in this area
Pharmaceutical Technology
OCTOBER 1, 2024
BioCryst Pharmaceuticals has received a contract valued at up to $69m from the US Department of Health and Human Services (HHS) for the procurement of RAPIVAB to treat influenza.
PharmExec
OCTOBER 1, 2024
Traci Miller (Director, Sonexus™ Access and Patient Support, Cardinal Health) discusses current digital trends in the patient services industry, as well as how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
Pharmaceutical Technology
OCTOBER 1, 2024
Ascendis Pharma has submitted a supplemental biologics licence application (sBLA) to the US Food and Drug Administration (FDA) for TransCon hGH to treat adults with growth hormone deficiency (GHD).
PharmExec
OCTOBER 1, 2024
Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Pharmaceutical Technology
OCTOBER 1, 2024
Aktis Oncology, a clinical-stage biotechnology company, has announced the successful closure of a $175m Series B financing round for advancing its radiopharmaceutical pipeline.
Pharma Marketing Network
OCTOBER 1, 2024
Pharma marketing strategies have evolved significantly over the years, adapting to changes in technology, regulatory landscapes, and consumer behavior. This article provides a comprehensive overview of the various facets of pharmaceutical marketing, from its historical evolution to future trends. By understanding these strategies, stakeholders in the pharmaceutical industry can better navigate the complexities of promoting their products effectively.
PharmExec
OCTOBER 1, 2024
Partnership is expected to leverage Amneal’s global manufacturing and product development experience and Metsera’s portfolio of ultra-long acting injectables and oral nutrient-stimulated hormone analogs.
PharmaTech
OCTOBER 1, 2024
Pharmaceutical Technology sat down with Anna Jenks, director of Pharmaceutical Operations for Merck & Co., Inc. in Rahway, NJ, USA to talk about her prologue presentation for AAPS PharmSci 360 2024.
PharmExec
OCTOBER 1, 2024
The application for Priority Review of Enhertu was supported by positive results from the DESTINY-Breast06 Phase III trial, which demonstrated that Enhertu reduced the risk of disease progression or death by 37% in patients with HER2-low or HER2-ultralow metastatic breast cancer.
Copyright Clearance Center
OCTOBER 1, 2024
October 1, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, will host “Let Licensing Bloom: The Root of Responsible AI” on 17 October, 3:00 – 4:00 pm CET at the 2024 Frankfurt Book Fair in Frankfurt Studio Hall 4.0, Room Europa. Panelists include Arend Kuester , CSIRO Publishing; Josh Jarrett , Wiley; Lui Simpson , Association of American Publishers (AAP); and Sarah Tegen , American Chemical Society (ACS).
PharmExec
OCTOBER 1, 2024
Joseph Panetta, President and CEO of Biocom California, shares his insights on biotech industry trends, policy challenges, and educational initiatives, drawing from over 25 years of leadership in California’s thriving life sciences sector.
Tribeca Knowledge
OCTOBER 1, 2024
M arket Access 2025, a new report from TRiBECA Knowledge, offers a fresh perspective on how the market access landscape for medicines continues to raise the bar for launch success and consistently better patient outcomes.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Optymyze
OCTOBER 1, 2024
At Optymyze, we are dedicated to providing effective solutions that make managing and interacting with data easier and more efficient. We are thrilled to introduce a major update to our.
PharmExec
OCTOBER 1, 2024
In this part of his Pharmaceutical Executive video interview, Jonathan Scheinberg, of the Northeast Science and Technology Center, explains how can companies position themselves to attract VC/federal funding, and identifies potential regulatory and policy implications of these trends.
Pharmaceutical Technology
OCTOBER 1, 2024
BPGbio has received a Rare Pediatric Disease Designation from the US Food and Drug Administration (FDA) for BPM31510IV to treat primary coenzyme Q10 deficiency, an ultra-rare mitochondrial disorder.
Pharmaceutical Commerce
OCTOBER 1, 2024
In the third part of his interview with Pharma Commerce Editor Nicholas Saraceno, Gautam Prem Jain, GoComet’s Co-founder and CEO, details the importance of E2E visibility.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
OCTOBER 1, 2024
Piramal Pharma Solutions, a contract development and manufacturing organisation, has announced an $80m investment to expand its sterile injectables facility in Lexington, Kentucky, in the US.
PharmExec
OCTOBER 1, 2024
CN201 is currently being evaluated in Phase I and Phase Ib/II clinical trials for relapsed or refractory non-Hodgkin lymphoma and B-cell acute lymphocytic leukemia.
Pharmaceutical Technology
OCTOBER 1, 2024
The 12th Annual Outsourcing in Clinical Trials & Clinical Trial Supply Nordics conference provided a venue to discuss the ideal criteria for CDMO partnerships.
PharmExec
OCTOBER 1, 2024
The Astellas chief commercial officer discusses the impact that the increase in global and local connectivity has had on commercialization, among other trends.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Expert insights. Personalized for you.
333 
Let's personalize your content